September 4, 2025
MetLife · Business Wire
MetLife Launches Cancer Support Benefit to Help Employees Understand and Navigate Care Options as Cancer Diagnoses Continue to Rise
MetLife introduced a new Cancer Support benefit through a strategic relationship with Private Health Management, expanding its Critical Illness Insurance offering to provide access to top oncology specialists, tech-enabled coordination, and patient counseling.
*Green Shoots served as interim finance leader for Private Health Management during this period and advised on the financial modeling for the MetLife partnership.
February 20, 2025
Variational AI · Business Wire
Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery
Variational AI closed an oversubscribed $5.5 million seed extension round led by Nimbus Synergies, with participation from Merck Global Health Innovation Fund and others, to expand its Enki™ generative AI platform for small molecule drug discovery.
*Green Shoots Consulting advised Merck Global Health Innovation Fund in connection with this transaction.
February 1, 2024
Avation Medical · PRNewswire
Avation Medical Raises $22M+ from Impressive Line-Up of New Global Investors to Jump-Start Sales of the First Closed-Loop Wearable Neuromodulation Technology for Bladder Treatment
Avation Medical announced more than $22 million in equity financing in its oversubscribed Series C round to fund the U.S. launch of its Vivally® System, the only FDA-cleared, non-invasive, closed-loop wearable neuromodulation device for overactive bladder.
*Allison Robbins, CFA served as Fractional CFO for Avation Medical and sourced a key investor in this round.
November 22, 2022
Turbine · Business Wire
Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World's First Cancer Cell Simulation Platform
Turbine, a company developing a cell behavior simulation platform, closed a €20 million Series A financing round co-led by Merck GHI and Mercia Asset Management to advance its cancer cell simulation programs toward the clinic.
*Green Shoots Consulting advised Merck Global Health Innovation Fund in connection with this transaction.
January 11, 2022
PreciseDx · PRNewswire
PreciseDx Raises $10.75 Million Series A Preferred from Healthcare Industry Leaders to Commercialize Cancer Risk Stratification Services to Support Better Patient Insights and Outcomes
PreciseDx, an AI-enabled cancer risk stratification platform spun out of Mount Sinai Health System, closed a $10.75 million Series A led by Merck Global Health Innovation Fund, with co-investment from Mount Sinai Health System, Agilent Technologies, IBM Ventures, and the Hobart Group.
*Green Shoots Consulting advised Merck Global Health Innovation Fund in connection with this transaction.
December 16, 2021
Verge Genomics · Business Wire
Verge Genomics Secures $98 Million in New Financing
Verge Genomics closed an oversubscribed $98 million Series B financing led by BlackRock, with participation from Lilly, Merck GHI, Section 32, and Vulcan Capital, to advance its AI-driven drug discovery platform toward the clinic.
*Green Shoots Consulting advised Merck Global Health Innovation Fund in connection with this transaction.
September 30, 2021
Green Shoots Consulting · PRNewswire
Green Shoots Consulting, LLC Co-Sponsors White Paper on Real-World Evidence Ecosystem
A white paper co-sponsored by Green Shoots Consulting describing the "Digital DNA" framework for the real-world evidence ecosystem, co-authored with colleagues from Merck Global Health Innovation Fund and Merck & Co.
*Allison Robbins, CFA is a co-author of this white paper alongside authors from Merck GHI and Merck & Co.
May 18, 2021
PathAI · PRNewswire
PathAI Announces Completion of $165 Million Financing for Advancing Medicine with AI-powered Pathology
PathAI closed a $165 million Series C co-led by D1 Capital Partners and Kaiser Permanente, with participation from General Atlantic, Tiger Global, Bristol-Myers Squibb, Labcorp, and Merck Global Health Innovation Fund, to expand its AI-powered pathology platform.
*Green Shoots Consulting advised Merck Global Health Innovation Fund in connection with this transaction.
March 23, 2021
McDermott Will & Emery
McDermott Represents Merck GHI in its Investment in M2GEN
McDermott Will & Emery represented Merck Global Health Innovation Fund in its investment to recapitalize M2GEN, a leading oncology data and informatics platform, alongside a significant new investment from CD&R and McKesson Ventures.
*Green Shoots Consulting advised Merck Global Health Innovation Fund in connection with this transaction.
March 17, 2021
M2GEN · PRNewswire
CD&R, Merck GHI, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Company M2GEN
M2GEN announced a significant new investment by Clayton, Dubilier & Rice, Merck Global Health Innovation Fund, and McKesson Ventures to recapitalize its leading oncology data and informatics platform focused on transforming cancer care.
*Green Shoots Consulting advised Merck Global Health Innovation Fund in connection with this transaction.
September 28, 2020
Koneksa · PRNewswire
Koneksa Completes $16M Series B Financing to Expand Digital Biomarker Platform
Koneksa, a leader in patient-centric digital biomarkers for drug development, completed a $16 million Series B led by Spring Mountain Capital, with participation from Merck Global Health Innovation Fund and others, to expand its digital platform for integrating wearables and sensors into clinical research.
*Green Shoots Consulting advised Merck Global Health Innovation Fund in connection with this transaction.
November 4, 2019
PathAI · PRWeb
PathAI Announces Strategic Investment from Merck Global Health Innovation Fund and Bristol-Myers Squibb to Complete $75M Series B Funding
PathAI completed its $75 million Series B financing with strategic investments from Merck Global Health Innovation Fund and Bristol-Myers Squibb, deepening the company's relationships with two leaders in cancer therapy development.
*Green Shoots Consulting advised Merck Global Health Innovation Fund in connection with this transaction.
February 5, 2019
AMRA Medical · PRNewswire
AMRA Medical Appoints Allison Robbins as Chief Financial Officer
AMRA Medical, a digital health company developing a global standard in body composition assessment through whole-body MRI, announced the appointment of Allison Robbins, CFA to its leadership team as Chief Financial Officer as the company prepared for continued growth and its next round of funding discussions.
*Allison Robbins served as CFO for AMRA Medical via Green Shoots Consulting, LLC.
November 29, 2017
electroCore · PRNewswire
electroCore Completes $70 Million Series B Funding Round
electroCore, a bioelectronic medicine company advancing neuromodulation therapies, completed a Series B financing of just over $70 million led by Core Ventures II, with significant participation from Merck Global Health Innovation Fund, a Series A investor in the company.
*Green Shoots Consulting advised Merck Global Health Innovation Fund in connection with this transaction.